GH: who owns it, and who’s predicted to buy next
Guardant Health Inc · Health Care · on the Prior Moves forward board for 2026-09-30 at rank #40. Research, not investment advice.
Predicted to buy next quarter
3 tracked investors are included in the model-ranked expectations for GH in 2026-09-30. This is a forecast about a later filing, not a confirmation that anyone has bought the security or a recommendation to do so.
- Lee Ainslie · Maverick
- Chuck Akre · Akre Capital
- Brad Gerstner · Altimeter
Strongest ranked investor signal: Daniel Loeb. No calibrated purchase probability is shown.
Currently disclosed holders
No investor in our tracked set discloses GH in their latest 13F. The prediction above is a forward call, not a mirror of current holdings.
Mutual fund and ETF holders
316 US mutual funds and ETFs from 172 fund families reported a position in GH for the quarter ending 2026-06-30. Against their own report a quarter earlier, 107 raised shares, 69 opened a new position, 105 cut and 47 sold out. Source: SEC Form N-PORT, which funds file about 60 days after quarter end. Share counts, not trades: a change can reflect fund inflows rather than a decision about GH.
| Fund family | Funds | Share of fund-held shares |
|---|---|---|
| Vanguard Index Funds | 4 | 29.0% |
| Ishares Trust | 10 | 6.5% |
| Mutual Fund Series Trust | 3 | 5.6% |
| T. Rowe Price New Horizons Fund, Inc. | 1 | 5.1% |
| Franklin Custodian Funds | 1 | 5.0% |
| Capitol Series Trust | 1 | 5.0% |
| American Funds Insurance Series | 2 | 2.8% |
| T. Rowe Price Health Sciences Fund, Inc. | 1 | 2.8% |
The predicted next buys, fresh disclosures, and the week’s catalysts. One email a week. Honest numbers, never advice.
See the full ranked board on top picks, how the PriorScore is built on how it works, the honest edge numbers on methodology, and the running accuracy on the prediction leaderboard. Forward quarter 2026-09-30, data as of 2026-10-16. Research, not investment advice, see the disclaimer.